Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Cedi depreciates by 9.5% in nine months of 2026 – BoG
According to the September 2026 Summary of Economic and Financial Data by the Bank of Ghana, the cedi traded at GH¢11.55 to one American greenback in September 2026.
Cedi depreciates by 9.5% in nine months of 2026 – BoG
According to the September 2026 Summary of Economic and Financial Data by the Bank of Ghana, the cedi traded at GH¢11.55 to one American greenback in September 2026.
Viking Stock Has Gained 254% Since Its IPO. Here's Whether That Run Is Anywhere Near Over.
The economy may be sputtering, but the luxury travel niche is not.
Finally, Some Good News for Lucid -- but There's a Catch
There's been plenty of bad news to digest for Lucid investors, but its recent partnership with Bolt in Europe is at least positive -- even if mostly hype for now.
Leon's Furniture Stock: Cash-Rich Retail Leader With an 11% Free Cash Flow Yield -- Is It a Buy for Long-Term Investors?
Key PointsThis $1.7 billion Canadian market cap company is showing strong results.